These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28650587)

  • 21. Role of lymph node dissection and splenectomy in node-positive gastric carcinoma.
    Adachi Y; Kamakura T; Mori M; Maehara Y; Sugimachi K
    Surgery; 1994 Nov; 116(5):837-41. PubMed ID: 7940186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.
    Son T; Hyung WJ; Lee JH; Kim YM; Kim HI; An JY; Cheong JH; Noh SH
    Cancer; 2012 Oct; 118(19):4687-93. PubMed ID: 22415925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients.
    Wang W; Xu DZ; Li YF; Guan YX; Sun XW; Chen YB; Kesari R; Huang CY; Li W; Zhan YQ; Zhou ZW
    Ann Oncol; 2011 Sep; 22(9):2049-2056. PubMed ID: 21310759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems.
    Choi YY; An JY; Katai H; Seto Y; Fukagawa T; Okumura Y; Kim DW; Kim HI; Cheong JH; Hyung WJ; Noh SH
    PLoS One; 2016; 11(3):e0149555. PubMed ID: 26967161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the optimal treatment strategy for early and advanced remnant gastric cancer.
    Hayashi M; Fujita T; Matsushita H
    ANZ J Surg; 2022 Nov; 92(11):2907-2914. PubMed ID: 36117449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
    Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lymph node ratio as a prognostic factor for gastric cancer.
    Nelen SD; van Steenbergen LN; Dassen AE; van der Wurff AA; Lemmens VE; Bosscha K
    Acta Oncol; 2013 Nov; 52(8):1751-9. PubMed ID: 23317142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of non-early gastric remnant carcinoma developing after distal gastrectomy for gastric cancer.
    Ohashi M; Morita S; Fukagawa T; Kushima R; Katai H
    J Surg Oncol; 2015 Feb; 111(2):208-12. PubMed ID: 25175816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
    Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
    Ji X; Fu T; Bu ZD; Zhang J; Wu XJ; Zong XL; Jia ZY; Fan B; Zhang YN; Ji JF
    BMC Cancer; 2016 Oct; 16(1):765. PubMed ID: 27716191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
    Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
    JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective clinicopathologic study of remnant gastric cancer after distal gastrectomy.
    Li F; Zhang R; Liang H; Zhao J; Liu H; Quan J; Wang X; Xue Q
    Am J Clin Oncol; 2013 Jun; 36(3):244-9. PubMed ID: 22495457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer.
    Li F; Zhang R; Liang H; Liu H; Quan J; Zhao J
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):111-7. PubMed ID: 22048654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
    Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
    Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging.
    Kong SH; Lee HJ; Ahn HS; Kim JW; Kim WH; Lee KU; Yang HK
    Ann Surg; 2012 Jan; 255(1):50-8. PubMed ID: 21577089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer.
    Liu H; Deng J; Zhang R; Hao X; Jiao X; Liang H
    Int J Surg; 2013; 11(5):419-24. PubMed ID: 23541652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of lymphadenectomy with splenectomy in radical surgery for advanced (pT3/pT4) remnant gastric cancer.
    Sugita H; Oda E; Hirota M; Ishikawa S; Tomiyasu S; Tanaka H; Arita T; Yagi Y; Baba H
    Surgery; 2016 Apr; 159(4):1082-9. PubMed ID: 26497772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging.
    Oh SE; An JY; Choi MG; Lee JH; Sohn TS; Bae JM
    Eur J Surg Oncol; 2020 Dec; 46(12):2236-2242. PubMed ID: 32788098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of prophylactic splenectomy for proximal advanced gastric cancer invading greater curvature.
    Ohkura Y; Haruta S; Shindoh J; Tanaka T; Ueno M; Udagawa H
    World J Surg Oncol; 2017 May; 15(1):106. PubMed ID: 28545537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and Long-term Outcomes of Surgical Treatment for Remnant Gastric Cancer After Distal Gastrectomy.
    Nakaji YU; Saeki H; Kudou K; Nakanishi R; Sugiyama M; Nakashima Y; Ando K; Oda Y; Oki E; Maehara Y
    Anticancer Res; 2019 Mar; 39(3):1411-1415. PubMed ID: 30842176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.